No Data
No Data
News Flash: 4 Analysts Think Exscientia Plc (NASDAQ:EXAI) Earnings Are Under Threat
Exscientia Reports Q2 Results
TD Cowen Maintains Exscientia(EXAI.US) With Hold Rating
Maintaining Hold Rating on Exscientia Plc Amid Anticipated Developments and Clinical Milestones
Exscientia's Strategic Merger and Pipeline Progress
Express News | Exscientia Q2 2024 GAAP EPS $(0.36) May Not Be Comparable To $(0.17) Estimate, Sales $5.600 May Not Be Comparable To $12.942M Estimate
No Data